Psychedelic Therapy: A Primer for Primary Care Clinicians— Ibogaine

The article provides a detailed overview of ibogaine, a plant-derived alkaloid with a long history of use in West-Central Africa for spiritual and medicinal purposes. In Western medicine, ibogaine has been studied primarily for its anti-addictive properties, especially in treating opioid and cocaine use disorders, and more recently for neuropsychiatric conditions such as PTSD, depression, and traumatic brain injury. The article highlights robust effects after a single treatment, including significant reductions in cravings and symptoms, but notes that safety concerns—particularly cardiotoxicity and dangerous drug interactions—require careful patient screening and monitoring. While observational studies and one randomized controlled trial show promising results, more large-scale, double-blind studies are needed to confirm efficacy and safety. The article also discusses ethical and sustainability issues related to ibogaine's sourcing and the importance of respecting indigenous practices.

Click HERE to DOWNLOAD for FREE